NR4A1 and breast carcinoma: Hormone receptors, ER/PR, HER2, triple negative, pathologic complete response, tumor size, tumor histology, TNM, multifocal or multicentric tumor, number of positive lymph nodes, or lymph node status/lymphovascular, lymphovascular invasion, N-stage, clinical presentation, grade, breast cancer subtype/molecular subtype